Priority Date: 13.09.11 (US 201161534330P)

MUTANT-SELECTIVE EGFR INHIBITORS AND USES THEREOF

  • Application ID: EP11839800
  • Status: The patent has been granted

Attorney

operating since 1989
Headquarter in Munich
active in Legal Services

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Wallinger Ricker Schlotter Tostmann Patent- und Rechtsanwälte Partnerschaft mbB is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 230 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 13.09.2011 - Priority Date (US 201161534330P)
  • 18.05.2012 - Publication A1 (WO2012064706)
  • 18.09.2013 - Publication A1 (EP2637502)
  • 10.01.2018 - Publication B1 (EP2637502)